All In MedTech

Device Trial Radar · NCT07040150

Evaluation of a Novel Semi-Rigid Brace for Adolescent Idiopathic Scoliosis

Development and Short-Term Evaluation of a Novel Semi-Rigid Brace for Adolescent Idiopathic Scoliosis: Results From a Multicenter Prospective Observational Study of the First 60 Patients

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

60

Actual

Start

Dec 24, 2019

Primary completion

Mar 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Nippon Sigmax co., ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jun 27, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 10 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Introduction: Spinal bracing remains the gold standard for conservative management of adolescent idiopathic scoliosis (AIS). However, poor adherence often limits treatment efficacy. The development of a brace that enhances compliance while maintaining sufficient corrective force is crucial. This study aimed to develop and evaluate the effectiveness of a novel semi-rigid brace for AIS based on wearing time and correction rate. Materials and Methods: The investigators enrolled patients who met the following Scoliosis Research Society (SRS) criteria for brace treatment: (1) confirmed AIS diagnosis, (2) Risser sign ≤ 2, (3) Cobb angle between 25° and 40°, (4) age ≥ 10 years, and (5) single-curve pattern. Wearing time was objectively measured over 180 days using embedded temperature sensors. Correction rates were assessed at initiation and after 180 days or more.

Conditions

  • Adolescent Idiopathic Scoliosis (AIS)

Interventions

  • Spinal bracingDevice

    The semi-rigid spinal brace was developed to enhance patient compliance while maintaining effective curve correction. Patients were instructed to wear the brace for 18-20 h daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wearing timeTime frame: 180 days from registration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Aizu Medical Center at Fukushima Medical University

    Aizu-Wakamatsu, Fukushima, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.